Crossref journal-article
Annual Reviews
Annual Review of Pharmacology and Toxicology (22)
Abstract

Tumor suppressor p53 is an attractive cancer therapeutic target because it can be functionally activated to eradicate tumors. Direct gene alterations in p53 or interaction between p53 and MDM2 proteins are two alternative mechanisms for the inactivation of p53 function. Designing small molecules to block the MDM2-p53 interaction and reactivate the p53 function is a promising therapeutic strategy for the treatment of cancers retaining wild-type p53. This review will highlight recent advances in the design and development of small-molecule inhibitors of the MDM2-p53 interaction as new cancer therapies. A number of these small-molecule inhibitors, such as analogs of MI-219 and Nutlin-3, have progressed to advanced preclinical development or early phase cinical trials.

Bibliography

Shangary, S., & Wang, S. (2009). Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy. Annual Review of Pharmacology and Toxicology, 49(1), 223–241.

Authors 2
  1. Sanjeev Shangary (first)
  2. Shaomeng Wang (additional)
References 102 Referenced 507
  1. 10.1038/sj.onc.1207116
  2. 10.1016/S0065-230X(08)60785-X
  3. 10.1038/35042675
  4. 10.1038/nrc864
  5. 10.1158/1078-0432.CCR-07-5136
  6. 10.1038/278261a0
  7. 10.1016/0092-8674(79)90293-9
  8. 10.1073/pnas.76.5.2420
  9. 10.1016/0092-8674(89)90045-7
  10. 10.1038/348747a0
  11. 10.1126/science.1978757
  12. 10.1016/j.critrevonc.2004.07.002
  13. 10.1016/0092-8674(92)90644-R
  14. 10.1002/j.1460-2075.1991.tb07676.x
  15. 10.1006/geno.1993.1058
  16. 10.1016/j.cell.2004.11.022
  17. 10.1038/358080a0
  18. 10.1038/sj.leu.2401619
  19. 10.2174/1568009053332636
  20. 10.1093/nar/26.15.3453
  21. 10.1038/modpathol.3880107
  22. 10.2174/1568009053332627
  23. 10.1038/sj.onc.1201702
  24. 10.1016/S0378-1119(99)00487-4
  25. 10.1093/emboj/19.19.5135
  26. 10.1016/0092-8674(93)90461-X
  27. 10.1016/S0002-9440(10)64853-5
  28. 10.1038/nature05541
  29. 10.1016/j.cell.2006.12.007
  30. 10.1038/nature05529
  31. 10.1038/nm0302-282
  32. 10.1038/nm1146
  33. 10.1016/j.molmed.2006.11.002
  34. 10.1126/science.1092472
  35. 10.1038/sj.cdd.4401921
  36. 10.1021/ja051147z
  37. 10.1073/pnas.0708917105
  38. 10.1007/s000180050273
  39. 10.1007/BF03402141
  40. 10.1101/gad.7.7a.1126
  41. 10.1038/378206a0
  42. 10.1038/378203a0
  43. 10.1128/MCB.23.2.462-473.2003
  44. 10.1128/MCB.13.7.4107
  45. {'key': 'B43', 'first-page': '2523', 'volume': '9', 'author': 'Picksley SM', 'year': '1994', 'journal-title': 'Oncogene'} / Oncogene by Picksley SM (1994)
  46. 10.1126/science.274.5289.948
  47. 10.4161/cc.3.4.801
  48. 10.1021/jm051122a
  49. 10.1158/1535-7163.MCT-08-0140
  50. 10.1021/jm049137g
  51. 10.1016/j.bmcl.2004.11.009
  52. 10.1158/1535-7163.MCT-05-0199
  53. 10.1002/anie.200462316
  54. 10.1158/1535-7163.MCT-04-0342
  55. 10.1021/jm060023+
  56. 10.1021/bi000930v
  57. 10.1021/jm034182u
  58. 10.1101/gad.8.10.1235
  59. {'key': 'B56', 'first-page': '2141', 'volume': '13', 'author': 'Bottger V', 'year': '1996', 'journal-title': 'Oncogene'} / Oncogene by Bottger V (1996)
  60. 10.1021/jm990966p
  61. 10.1021/ci00021a032
  62. 10.1021/ci000150t
  63. 10.1006/jmbi.1996.0897
  64. 10.1002/prot.10465
  65. 10.1023/A:1007996124545
  66. 10.1023/A:1016357811882
  67. 10.1021/ja073687x
  68. 10.1021/ja026861k
  69. 10.2174/0929867053363153
  70. 10.1016/j.bmcl.2006.04.009
  71. 10.1074/jbc.C600147200
  72. 10.1038/nature05194
  73. 10.1158/0008-5472.CAN-05-3832
  74. 10.4161/cc.7.13.6072
  75. 10.1074/jbc.M605405200
  76. 10.1074/jbc.M410233200
  77. 10.1158/1541-7786.MCR-07-0161
  78. 10.1158/1078-0432.CCR-08-0150
  79. {'key': 'B74', 'first-page': '1169', 'volume': '54', 'author': 'el-Deiry WS', 'year': '1994', 'journal-title': 'Cancer Res.'} / Cancer Res. by el-Deiry WS (1994)
  80. 10.1016/S1097-2765(00)80002-7
  81. 10.1073/pnas.0507493103
  82. 10.1016/j.ccr.2006.10.010
  83. 10.1182/blood-2005-02-0553
  84. 10.1161/01.RES.0000253975.76198.ff
  85. 10.1182/blood-2005-11-4465
  86. 10.1182/blood-2005-12-5148
  87. 10.1182/blood-2005-08-3273
  88. 10.1182/blood-2007-09-112698
  89. 10.1182/blood-2005-04-1489
  90. 10.1016/j.bcmd.2007.04.002
  91. 10.1158/0008-5472.CAN-04-3576
  92. 10.1158/0008-5472.CAN-06-1527
  93. 10.1038/sj.onc.1202281
  94. 10.1002/j.1460-2075.1996.tb00919.x
  95. 10.1128/MCB.20.3.1001-1007.2000
  96. 10.1016/S0014-5793(99)00254-9
  97. 10.1038/ng714
  98. 10.1128/MCB.22.15.5527-5538.2002
  99. 10.4161/cc.6.19.4740
  100. 10.1172/JCI30945
  101. 10.1038/362847a0
  102. 10.1002/stem.150082
Dates
Type When
Created 16 years, 10 months ago (Oct. 3, 2008, 5:19 p.m.)
Deposited 3 years, 10 months ago (Oct. 16, 2021, 4:50 a.m.)
Indexed 4 weeks, 1 day ago (July 22, 2025, 7:03 a.m.)
Issued 16 years, 6 months ago (Feb. 1, 2009)
Published 16 years, 6 months ago (Feb. 1, 2009)
Published Print 16 years, 6 months ago (Feb. 1, 2009)
Funders 0

None

@article{Shangary_2009, title={Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy}, volume={49}, ISSN={1545-4304}, url={http://dx.doi.org/10.1146/annurev.pharmtox.48.113006.094723}, DOI={10.1146/annurev.pharmtox.48.113006.094723}, number={1}, journal={Annual Review of Pharmacology and Toxicology}, publisher={Annual Reviews}, author={Shangary, Sanjeev and Wang, Shaomeng}, year={2009}, month=feb, pages={223–241} }